Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.32 - $2.12 $97,251 - $156,191
-73,675 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.69 - $5.81 $11,238 - $38,636
6,650 Added 9.92%
73,675 $125,000
Q4 2021

Feb 14, 2022

BUY
$4.09 - $8.67 $114,659 - $243,054
28,034 Added 71.9%
67,025 $355,000
Q3 2021

Nov 15, 2021

BUY
$6.6 - $12.78 $257,340 - $498,304
38,991 New
38,991 $321,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.